ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Generic Testosterone Gel Company Sues the FDA for Failure to Inform the Public
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 7035" data-attributes="member: 3"><p>Perrigo Israel Pharmaceuticals is going to bat against the United States Food and Drug Administration (“FDA”) over its “failure” to <a href="http://www.law360.com/articles/520958/perrigo-sues-fda-for-failing-to-publish-approval-of-gel" target="_blank">announce</a> the approval of a testosterone gel.</p><p></p><p>Perrigo's product, a generic testosterone gel 1% is bioequivalent to AbbVie's Androgel. It was<a href="http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203098Orig1s000Approv.pdf" target="_blank">approved</a> January 31, 2013 by the FDA, and Perrigo claims it asked the FDA to publish its “therapeutic equivalence evaluation” (TE) ratings in the “Orange Book,” which the FDA is required to update every 30 days with drugs that are approved.</p><p></p><p><strong>Why is the “Orange Book” important?</strong></p><p><strong></strong></p><p>The Orange Book is filled with FDA-approved drug products. Staff members compiled it in October 1980. The Orange Book Search can also be found on the FDA's website, where it has been since October 31, 1997.</p><p></p><p>Perrigo filed its <a href="http://www.hpm.com/pdf/blog/Testosterone%20Gel%20-%20Perrigo%20Complaint.pdf" target="_blank">case</a> on March 21st, 2014 in the United States District Court for the District of Columbia (Case 1:14-cv-00475). In the document, Perrigo claims it was and is the FDA's “duty” to update the “Orange Book.” The company claims the FDA published other TE ratings for several other drugs that had been approved “after” Perrigo's testosterone gel product.</p><p></p><p>Perrigo is asking for a “mandatory injunction” to force the FDA to publish a TE rating for the company's product.</p><p></p><p>Note: We are trying to contact the company to see what their pricing is like compared to Androgel and other products approved in the US.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 7035, member: 3"] Perrigo Israel Pharmaceuticals is going to bat against the United States Food and Drug Administration (“FDA”) over its “failure” to [URL="http://www.law360.com/articles/520958/perrigo-sues-fda-for-failing-to-publish-approval-of-gel"]announce[/URL] the approval of a testosterone gel. Perrigo's product, a generic testosterone gel 1% is bioequivalent to AbbVie's Androgel. It was[URL="http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203098Orig1s000Approv.pdf"]approved[/URL] January 31, 2013 by the FDA, and Perrigo claims it asked the FDA to publish its “therapeutic equivalence evaluation” (TE) ratings in the “Orange Book,” which the FDA is required to update every 30 days with drugs that are approved. [B]Why is the “Orange Book” important? [/B] The Orange Book is filled with FDA-approved drug products. Staff members compiled it in October 1980. The Orange Book Search can also be found on the FDA's website, where it has been since October 31, 1997. Perrigo filed its [URL="http://www.hpm.com/pdf/blog/Testosterone%20Gel%20-%20Perrigo%20Complaint.pdf"]case[/URL] on March 21st, 2014 in the United States District Court for the District of Columbia (Case 1:14-cv-00475). In the document, Perrigo claims it was and is the FDA's “duty” to update the “Orange Book.” The company claims the FDA published other TE ratings for several other drugs that had been approved “after” Perrigo's testosterone gel product. Perrigo is asking for a “mandatory injunction” to force the FDA to publish a TE rating for the company's product. Note: We are trying to contact the company to see what their pricing is like compared to Androgel and other products approved in the US. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Generic Testosterone Gel Company Sues the FDA for Failure to Inform the Public
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top